Viewing Study NCT06469788



Ignite Creation Date: 2024-07-17 @ 11:45 AM
Last Modification Date: 2024-10-26 @ 3:32 PM
Study NCT ID: NCT06469788
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-06-24
First Post: 2024-06-14

Brief Title: Testimonials and Navigation in Rheumatology
Sponsor: University of Alabama at Birmingham
Organization: University of Alabama at Birmingham

Study Overview

Official Title: Improving COVID-19 Vaccine Uptake Among Racial and Ethnic Minority Groups With Rheumatic Diseases
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: TANGO
Brief Summary: The overall goal of this study is to determine whether a novel multi-modal patient-directed behavioral intervention initiated in rheumatology clinics is an effective approach to improve uptake of updated COVID-19 vaccine
Detailed Description: Black and Latinx persons are at higher risk for certain autoimmune and inflammatory rheumatic diseases AIRD and have experienced worse COVID-19 outcomes compared to their white counterparts Given the risks of severe COVID-19 outcomes such as hospitalization and death in people with AIRD COVID-19 vaccine is recommended in this population Historically overall vaccine uptake among people with AIRDs has been low and this vaccine reluctance has extended to COVID-19 vaccination While additional COVID-19 vaccine doses have offered considerable added protection against severe outcomes only 20 of all vaccinated persons in Alabama AL and 45 in Massachusetts have obtained an additional dose of COVID-19 vaccine as of October 2022 Racial and ethnic minority groups have faced disparities in obtaining subsequent COVID-19 vaccines particularly in under-resourced communities including those in Alabama and Massachusetts Together these obstacles exacerbate existing health inequities among people of color and perpetuate worse COVID-19 outcomes

We will conduct a randomized controlled study to test an intervention that seeks to address gaps in COVID-19 vaccine information and access inequities common in Black and Latinx populations

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
5R01MD019235 NIH None None